A study has indicated that capping the cost of insulin at $35 per month may lead to better adherence to treatment for those with type 2 diabetes.
This finding underscores the importance of medication affordability in managing chronic conditions.
As discussions around healthcare costs continue, this research may inform policies aimed at improving access to essential medications.